Van Plew Daniel P 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2022/11/8 申報
- 申報編號
- 0001883850-22-000092
- 申報時間
- 2022/11/8
- 交易日
- 2022/11/4-11/7
- 申報延遲
- 4 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 8 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $587.8 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Van Plew Daniel PCIK 0001411984 | 高階主管（EVP & General Mgr, Industrial） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/11/4 | Common Stock | M行使選擇權取得 | +34,000 | $381.92 | +$12,985,280 | 64,578 | 直接 | |
| 2022/11/4 | Common Stock | F扣股繳稅處分 | −26,114 | $725.84 | −$18,954,585.76 | 38,464 | 直接 | |
| 2022/11/7 | Common Stock | S賣出處分 | −100 | $742.79 | −$74,279 | 38,364 | 直接 | |
| 2022/11/7 | Common Stock | S賣出處分 | −1,100 | $743.39F1 | −$817,729 | 37,264 | 直接 | |
| 2022/11/7 | Common Stock | S賣出處分 | −2,032 | $744.61F2 | −$1,513,047.52 | 35,232 | 直接 | |
| 2022/11/7 | Common Stock | S賣出處分 | −1,468 | $745.51F3 | −$1,094,408.68 | 33,764 | 直接 | |
| 2022/11/7 | Common Stock | S賣出處分 | −2,782 | $746.56F4 | −$2,076,929.92 | 30,982 | 直接 | |
| 2022/11/7 | Common Stock | S賣出處分 | −404 | $747.20F5 | −$301,868.8 | 30,578 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/11/4 | Common Stock | M行使選擇權處分 | −34,000 | $0.00 | $0 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 7, 2022 at prices ranging from $743.00 to $743.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F2
Represents volume-weighted average price of sales of 2,032 shares of Company stock on November 7, 2022 at prices ranging from $744.02 to $744.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 1,468 shares of Company stock on November 7, 2022 at prices ranging from $745.00 to $745.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 2,782 shares of Company stock on November 7, 2022 at prices ranging from $746.15 to $746.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 404 shares of Company stock on November 7, 2022 at prices ranging from $747.00 to $747.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。